Invivoscribe, Complete Genomics to Develop Cancer Biomarker Tests
Invivoscribe and Complete Genomics have partnered to develop and commercialize cancer biomarker tests on Complete Genomics’ NGS platforms.
Read More
Search Results for: leukemia
Panel Detects BCR-ABL1 Oncogene Isoform Co-Expression in CML Patient
The HemeScreen BCR-ABL1 Panel enabled Precipio’s clinical lab to detect a co-expression of both p190 and p210 isoforms in this patient, leading to more informed care decisions.
Read More
How Labs Are Meeting the Challenges of the Post-Pandemic World
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read More
Alercell Launches LENA Molecular Dx Leukemia Platform
The LENA Molecular Dx Leukemia Platform is a core group of 12 molecular diagnostic tests that can be processed on a standard qPCR machine.
Read More
As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read More